Vous êtes sur la page 1sur 18

Sales 94% 143% 140% 139% 144% 170% 104% 111% 84%

Expenses 110% 143% 128% 142% 170% 170% 106% 102% 102%
Operating Profit 73% 144% 163% 134% 104% 170% 98% 135% 46%
Net profit 74% 134% 146% 112% 105% 144% 100% 153% 31%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Trailing Best Case Worst Case 1.01
Sales 4,272.30 4,007.45 5,727.90 8,019.49 11,130.57 16,080.36 27,392.01 28,487.03 31,578.44 26,489.46 27,792.13 27,792.13 26,180.80 1.22
Expenses 2,408.35 2,644.12 3,768.00 4,816.28 6,824.44 11,598.00 19,763.06 21,013.88 21,489.17 21,831.83 21,517.35 20,657.44 20,269.82 1.28
Operating Profit 1,863.95 1,363.33 1,959.90 3,203.21 4,306.13 4,482.36 7,628.95 7,473.15 10,089.27 4,657.63 6,274.78 7,134.69 5,910.98 1.11
Operating Profit % 43.63 34.02 34.22 39.94 38.69 27.87 27.85 26.23 31.95 17.58 22.58 25.67 22.58 0.90
Other Income 214.36 210.97 354.78 471.51 -89.97 -1,678.58 490.56 69.47 623.15 -108.50 -231.54 - - -0.93
Other Income % 12% 15% 18% 15% -2% -37% 6% 1% 6% -2% -4% 0% 0% -0.84
EBIDT 2,078.31 1,574.30 2,314.68 3,674.72 4,216.16 2,803.78 8,119.51 7,542.62 10,712.42 4,549.13 6,043.24 7,134.69 5,910.98 1.09
EBIDT % 48.65 39.28 40.41 45.82 37.88 17.44 29.64 26.48 33.92 17.17 21.74 25.67 22.58 0.89
Depreciation 123.29 153.31 204.85 291.16 336.17 409.23 1,194.72 1,037.53 1,264.75 1,499.84 1,622.71 1,622.71 1,622.71 1.32
Interest 5.85 6.15 73.88 28.20 43.16 44.19 578.99 523.24 399.80 517.57 511.14 511.14 511.14 1.65
Interest Coverage Ratio 318.62 221.68 26.53 113.59 99.77 101.43 13.18 14.28 25.24 9.00 12.28 13.96 11.56 0.67
Profit before tax 1,949.17 1,414.84 2,035.95 3,355.36 4,314.89 4,581.17 6,402.90 6,570.63 9,047.87 3,478.98 3,909.39 5,000.84 3,777.13 1.07
Profit before tax % 45.62 35.31 35.54 41.84 38.77 28.49 23.38 23.07 28.65 13.13 14.07 17.99 14.43 0.87
Tax 71.16 67.86 128.58 313.19 845.55 702.17 914.69 913.77 1,211.57 845.19 954.78 24% 24% 1.32
Tax % 3.65 4.80 6.32 9.33 19.60 15.33 14.29 13.91 13.39 24.29 24.42 0.00 0.01 1.23
Net profit 1,817.73 1,351.08 1,816.06 2,656.69 2,983.06 3,141.47 4,539.38 4,545.71 6,964.37 2,161.55 2,676.57 3,779.50 2,854.65 1.02
Net profit % 42.55 33.71 31.71 33.13 26.80 19.54 16.57 15.96 22.05 8.16 9.63 13.60 10.90 0.83
EPS 8.78 6.52 8.77 12.83 14.40 15.17 21.92 18.89 29.03 9.01 11.16 15.75 11.90 1.00
Price to earning 13.32 26.60 25.41 22.79 31.03 40.19 47.41 43.26 22.93 56.97 37.71 40.22 33.42 1.18
Price 116.89 173.55 222.81 292.32 446.96 609.62 1,039.00 817.16 665.60 513.23 420.65 633.51 397.62 1.18
#DIV/0!
RATIOS: #DIV/0!
Dividend Payout 15.67% 21.08% 19.96% 16.57% 8.68% 9.89% 13.69% 5.29% 12.06% 22.20% 1.04
OPM 43.63% 34.02% 34.22% 39.94% 38.69% 27.87% 27.85% 26.23% 31.95% 17.58% 22.58% 0.90

Price/Sales 2.74%
TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST
Sales Growth 22.47% 24.45% 18.94% -1.11% 4.92% 4.92% -1.11%
OPM 28.82% 28.05% 26.40% 25.67% 22.58% 25.67% 22.58%
Price to Earning 33.42 37.79 41.41 40.22 37.71 40.22 33.42
Sales 100% 96% 90% 87% 107% 100% 105%
Expenses 95% 107% 102% 91% 103% 99% 102%
Operating Profit 108% 77% 63% 71% 126% 106% 116%
Net profit 109% 60% 83% -26% -311% 36% 358%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18
Sales 8,256.26 8,260.11 7,925.11 7,136.96 6,208.79 6,650.34 6,653.23 6,977.10 7,224.17 6,937.63
Expenses 5,335.28 5,092.42 5,471.98 5,589.48 5,113.14 5,274.73 5,199.85 5,293.61 5,617.47 5,406.42
Operating Profit 2,920.98 3,167.69 2,453.13 1,547.48 1,095.65 1,375.61 1,453.38 1,683.49 1,606.70 1,531.21
Other Income 157.10 119.40 122.15 224.50 -798.52 254.84 129.19 302.75 199.75 -863.23
Depreciation 315.95 303.83 306.80 338.17 346.63 358.65 339.32 455.24 401.64 426.51
Interest 134.62 53.72 166.47 44.99 109.42 157.44 95.33 155.38 130.90 129.53
Profit before tax 2,627.51 2,929.54 2,102.01 1,388.82 -158.92 1,114.36 1,147.92 1,375.62 1,273.91 111.94
Tax 352.71 441.65 372.92 44.30 161.78 111.40 748.70 -176.69 163.86 218.91
Net profit 2,267.71 2,471.11 1,471.82 1,223.71 -322.60 1,001.79 365.39 1,308.96 1,111.06 -108.84

OPM 35% 38% 31% 22% 18% 21% 22% 24% 22% 22%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 103.56 103.56 103.56 103.56 103.56 207.12 207.12 240.66 239.93 239.93
Reserves 6,941.36 7,725.35 9,379.76 12,132.22 14,886.17 18,317.83 25,378.61 32,741.15 36,399.74 37,860.63
Total Shareholder Funds 7,044.92 7,828.91 9,483.32 12,235.78 14,989.73 18,524.95 25,585.73 32,981.81 36,639.67 38,100.56
Borrowings 178.89 171.15 425.58 320.73 259.71 2,560.86 8,996.11 8,496.76 9,831.77 10,385.27
Other Liabilities 1,039.64 1,072.02 2,464.24 3,945.84 5,343.30 8,298.29 14,635.55 14,463.02 15,440.35 16,505.14
Total 8,263.45 9,072.08 12,373.14 16,502.35 20,592.74 29,384.10 49,217.39 55,941.59 61,911.79 64,990.97
Debt/Equity Ratio 0.03 0.02 0.04 0.03 0.02 0.14 0.35 0.26 0.27 0.27
Current Ratio 3.39 2.57 1.95 1.91 1.69 1.56 1.49 1.82 1.89 1.49
Net Block 1,787.88 1,938.82 3,293.35 3,951.35 5,647.47 6,817.28 12,682.47 15,872.25 17,675.17 18,852.65
Capital Work in Progress 157.10 144.82 235.46 344.65 562.61 841.54 2,038.61 2,175.45 2,801.38 2,465.16
Investments 1,859.49 3,166.38 2,229.76 2,212.87 2,411.57 2,786.02 2,716.30 1,829.88 1,191.88 7,142.87
Other Assets 4,458.98 3,822.06 6,614.57 9,993.48 11,971.09 18,939.26 31,780.01 36,064.01 40,243.36 36,530.29
Total 8,263.45 9,072.08 12,373.14 16,502.35 20,592.74 29,384.10 49,217.39 55,941.59 61,911.79 64,990.97

Working Capital 3,419.34 2,750.04 4,150.33 6,047.64 6,627.79 10,640.97 17,144.46 21,600.99 24,803.01 20,025.15
Debtors 881.09 1,174.77 1,104.87 2,078.74 2,412.23 2,200.42 5,106.13 6,775.66 7,202.61 7,815.28
Inventory 975.70 1,073.85 1,489.48 2,086.98 2,577.76 3,123.01 5,667.99 6,422.54 6,832.81 6,880.69

Debtor Days 75.28 107.00 70.41 94.61 79.10 49.95 68.04 86.82 83.25 107.69
Inventory Turnover 4.38 3.73 3.85 3.84 4.32 5.15 4.83 4.44 4.62 3.85

Return on Equity 26% 17% 19% 22% 20% 17% 18% 14% 19% 6%
Return on Capital Emp 32% 24% 22% 26% 25% 19% 19% 15% 18% 6%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 2,165.07 781.13 2,281.13 2,234.46 3,356.58 3,959.20 5,615.74 6,685.86 7,082.21 3,907.15 38,068.53 1.07
Cash from Investing Activity -1,484.35 -213.74 -1,300.32 -747.89 -2,375.15 -2,176.18 -1,502.35 -3,949.13 -4,186.15 -3,103.80 -21,039.06 1.09
Cash from Financing Activity -266.73 -346.43 -804.19 -544.39 -664.99 506.57 -1,186.53 -1,888.53 -2,285.39 -1,539.26 -9,019.87 1.22
Net Cash Flow 413.99 220.96 176.62 942.18 316.44 2,289.59 2,926.86 848.20 610.67 -735.91 8,009.60

Net profit 1817.73 1351.08 1816.06 2656.69 2983.06 3141.47 4539.38 4545.71 6964.37 2161.55 31,977.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.


Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.


Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.

dalal-street.in
COMPANY NAME SUN PHARMACEUTICALS INDUSTRIES LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10

META
Number of shares 239.93
Face Value 1
Current Price 420.65
Market Capitalization 100927.74

PROFIT & LOSS


Report Date Mar-09 Mar-10 Mar-11 Mar-12
Sales 4,272.30 4,007.45 5,727.90 8,019.49
Raw Material Cost 949.35 1,130.17 1,666.46 2,088.80
Change in Inventory 93.73 32.44 205.77 448.87
Power and Fuel 97.77 91.92 96.78 145.65
Other Mfr. Exp 154.96 190.22 338.40 470.33
Employee Cost 340.12 400.79 818.95 1,187.73
Selling and admin 839.48 710.16 852.80 1,146.03
Other Expenses 120.40 153.30 200.38 226.61
Other Income 214.36 210.97 354.78 471.51
Depreciation 123.29 153.31 204.85 291.16
Interest 5.85 6.15 73.88 28.20
Profit before tax 1,949.17 1,414.84 2,035.95 3,355.36
Tax 71.16 67.86 128.58 313.19
Net profit 1,817.73 1,351.08 1,816.06 2,656.69
Dividend Amount 284.79 284.79 362.46 440.13

Quarters
Report Date Jun-16 Sep-16 Dec-16 Mar-17
Sales 8,256.26 8,260.11 7,925.11 7,136.96
Expenses 5,335.28 5,092.42 5,471.98 5,589.48
Other Income 157.10 119.40 122.15 224.50
Depreciation 315.95 303.83 306.80 338.17
Interest 134.62 53.72 166.47 44.99
Profit before tax 2,627.51 2,929.54 2,102.01 1,388.82
Tax 352.71 441.65 372.92 44.30
Net profit 2,267.71 2,471.11 1,471.82 1,223.71
Operating Profit 2920.98 3167.69 2453.13 1547.48
BALANCE SHEET
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Equity Share Capital 103.56 103.56 103.56 103.56
Reserves 6941.36 7725.35 9379.76 12132.22
Borrowings 178.89 171.15 425.58 320.73
Other Liabilities 1039.64 1072.02 2464.24 3945.84
Total 8,263.45 9,072.08 12,373.14 16,502.35
Net Block 1787.88 1938.82 3293.35 3951.35
Capital Work in Progress 157.1 144.82 235.46 344.65
Investments 1859.49 3166.38 2229.76 2212.87
Other Assets 4458.98 3822.06 6614.57 9993.48
Total 8,263.45 9,072.08 12,373.14 16,502.35
Receivables 881.09 1,174.77 1,104.87 2,078.74
Inventory 975.7 1073.85 1489.48 2086.98
Cash & Bank 1669.03 508.89 2204.63 3367.19
No. of Equity Shares 207116391 207116391 1035581955 1035581955
New Bonus Shares
Face value 5 5 1 1

CASH FLOW:
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Cash from Operating Activity 2,165.07 781.13 2,281.13 2,234.46
Cash from Investing Activity -1,484.35 -213.74 -1,300.32 -747.89
Cash from Financing Activity -266.73 -346.43 -804.19 -544.39
Net Cash Flow 413.99 220.96 176.62 942.18

PRICE: 116.89 173.55 222.81 292.32

DERIVED:
Adjusted Equity Shares in Cr 207.12 207.12 207.12 207.12
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18


11,130.57 16,080.36 27,392.01 28,487.03 31,578.44 26,489.46
2,301.82 2,855.86 6,624.68 6,724.15 8,402.37 7,193.98
228.48 76.54 -114.49 393.77 271.63 -230.70
187.10 232.41 560.77 545.44 525.09 559.97
621.45 813.85 1,427.56 1,808.55 1,973.46 1,828.35
1,534.53 2,074.44 4,502.64 4,772.31 4,902.30 5,367.05
1,556.39 2,373.26 5,131.37 5,219.20 5,224.61 4,727.00
851.63 3,324.72 1,401.55 2,338.00 732.97 1,924.78
-89.97 -1,678.58 490.56 69.47 623.15 -108.50
336.17 409.23 1,194.72 1,037.53 1,264.75 1,499.84
43.16 44.19 578.99 523.24 399.80 517.57
4,314.89 4,581.17 6,402.90 6,570.63 9,047.87 3,478.98
845.55 702.17 914.69 913.77 1,211.57 845.19
2,983.06 3,141.47 4,539.38 4,545.71 6,964.37 2,161.55
258.90 310.68 621.36 240.66 839.75 479.86

Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18


6,208.79 6,650.34 6,653.23 6,977.10 7,224.17 6,937.63
5,113.14 5,274.73 5,199.85 5,293.61 5,617.47 5,406.42
-798.52 254.84 129.19 302.75 199.75 -863.23
346.63 358.65 339.32 455.24 401.64 426.51
109.42 157.44 95.33 155.38 130.90 129.53
-158.92 1,114.36 1,147.92 1,375.62 1,273.91 111.94
161.78 111.40 748.70 -176.69 163.86 218.91
-322.60 1,001.79 365.39 1,308.96 1,111.06 -108.84
1095.65 1375.61 1453.38 1683.49 1606.7 1531.21
Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
103.56 207.12 207.12 240.66 239.93 239.93
14886.17 18317.83 25378.61 32741.15 36399.74 37860.63
259.71 2560.86 8996.11 8496.76 9831.77 10385.27
5343.3 8298.29 14635.55 14463.02 15440.35 16505.14
20,592.74 29,384.10 49,217.39 55,941.59 61,911.79 64,990.97
5647.47 6817.28 12682.47 15872.25 17675.17 18852.65
562.61 841.54 2038.61 2175.45 2801.38 2465.16
2411.57 2786.02 2716.3 1829.88 1191.88 7142.87
11971.09 18939.26 31780.01 36064.01 40243.36 36530.29
20,592.74 29,384.10 49,217.39 55,941.59 61,911.79 64,990.97
2,412.23 2,200.42 5,106.13 6,775.66 7,202.61 7,815.28
2577.76 3123.01 5667.99 6422.54 6832.81 6880.69
4058.71 7590.15 10998.04 13181.65 15140.84 9929.38
1035581955 2071163910 2071163910 2406605118 2399260815 2399260815
1035581960
1 1 1 1 1 1

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18


3,356.58 3,959.20 5,615.74 6,685.86 7,082.21 3,907.15
-2,375.15 -2,176.18 -1,502.35 -3,949.13 -4,186.15 -3,103.80
-664.99 506.57 -1,186.53 -1,888.53 -2,285.39 -1,539.26
316.44 2,289.59 2,926.86 848.20 610.67 -735.91

446.96 609.62 1,039.00 817.16 665.60 513.23

207.12 207.12 207.12 240.66 239.93 239.93